Taking stock and looking ahead: Behavioural science lessons for implementing the nonavalent human papillomavirus vaccine

The development and licensing of a nonavalent human papillomavirus (HPV) vaccine has the potential to reduce morbidity and mortality from HPV-related cancers beyond that of first generation HPV vaccines. However, this benefit can only be realised if the offer of vaccination is accepted. Uptake of fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Forster, Alice S., Waller, Jo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Ltd 2016
Materias:
Current Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920641/
https://www.ncbi.nlm.nih.gov/pubmed/27235782
http://dx.doi.org/10.1016/j.ejca.2016.04.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920641/
https://www.ncbi.nlm.nih.gov/pubmed/27235782
http://dx.doi.org/10.1016/j.ejca.2016.04.014

Ejemplares similares